Jennifer Brigitte Green

Dr. Green’s research has focused primarily upon strategies to predict, prevent, and treat diabetes mellitus.  In particular, she is interested in the effects of various interventions to modify glycemic control, dyslipidemia, and hypertension upon cardiovascular and other diabetes-related complications.  She has served as an investigator in federally funded clinical trials of type 2 diabetes management including ACCORD, BARI 2D, and GRADE, and is a member of the data and safety monitoring board for the NIDDK consortium of artificial pancreas studies. Her work with the DCRI has included protocol development, oversight of adjudication committees, and clinical and operational leadership for several large, international trials designed to determine the cardiovascular effects of glucose-lowering medications (TECOS, EXSCEL, Harmony Outcomes).  She has recently been appointed PI of the US Coordinating Center for EMPA-KIDNEY: A Multicentre International Randomized Parallel Group Double-Blind Placebo-Controlled Clinical Trial of Empagliflozin Once Daily To Assess Cardio-Renal Outcomes in Patients With Chronic Kidney Disease. Dr. Green also leads a study team within the DCRI and Duke Data Science groups focused upon utilization of electronic health data to guide and improve medical decision-making in the care of patients with diabetes.

A full listing of publications to which I have contributed can be found here:

https://www.ncbi.nlm.nih.gov/sites/myncbi/1N3tmspW86aAM/bibliography/47644101/public/?sort=date&direction=descending